Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 6401168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].

  1982cited by this paper
• Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).

  1982cited by this paper
• Evidence for different localization of glutathione oxidase and gamma-glutamyltransferase activities during extracellular glutathione metabolism in isolated perfused rat kidney.

  1982cited by this paper
• Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds.

  1981cited by this paper
• Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds.

  1981cited by this paper
• [Pharmacokinetics of Uromitexan].

  1981cited by this paper
• Characteristics of glutathione biosynthesis by freshly isolated rat kidney cells.

  1980cited by this paper
• High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides.

  1980cited by this paper
• Translocation of amino acids and glutathione studied with the perfused kidney and isolated renal cells

  1980cited by this paper
• Isolation of anthglutin, an inhibitor of gamma-glutamyl transpeptidase from Penicillum oxalicum.

  1979cited by this paper
• Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.

  1979cited by this paper
• [Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide].

  1979cited by this paper
• Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.

  1979cited by this paper
• Metabolic activation and hepatotoxicity. Effect of cysteine, N-acetylcysteine, and methionine on glutathione biosynthesis and bromobenzene toxicity in isolated rat hepatocytes.

  1979cited by this paper
• Xenobiotic metabolism by isolated intestinal epithelial cells from guinea-pigs.

  1979cited by this paper
• Use of isolated kidney cells for study of drug metabolism.

  1979cited by this paper
• Isolation of anthglutin, an inhibitor of γ-glutamyl transpeptidase from Penicillum oxalicum

  1979cited by this paper
• Glutathione Efflux from Perfused Rat Liver and Its Relation to Glutathione Uptake by the Kidney

  1978cited by this paper
• [4] Isolation and use of liver cells

  1978cited by this paper
• Evidence that the gamma-glutamyl cycle functions in vivo using intracellular glutathione: effects of amino acids and selective inhibition of enzymes.

  1978cited by this paper
• The γ-Glutamyl Cycle: A Possible Transport System for Amino Acids

  1970cited by this paper
• The gamma-glutamyl cycle: a possible transport system for amino acids.

  1970cited by this paper
• A purified plasma membrane fraction isolated from rat liver under isotonic conditions.

  1967cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper
• A scheme for the colorimetric determination of microgram amounts of thiols

  1958cited by this paper

• Kinetic Analysis of the Reduction Processes of a Cisplatin Pt(IV) Prodrug by Mesna, Thioglycolic Acid, and Thiolactic Acid

  2020cites this paper
• U . S . ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE USAMRICD-TR-0105 Effects of Sodium 2-Mercaptoethanesulfonate ( Mesna ) as a Post-treatment in Mice Challenged with Phosgene

  2018cites this paper
• Enzymatic and non-enzymatic mechanisms of dimesna metabolism

  2015influential citation
• The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna

  2014cites this paper
• In Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna

  2012influential citation
• Accumulation of BNP7787 in human renal proximal tubule cells.

  2011cites this paper
• Tavocept (BNP7787) : a novel chemoprotector/sensitizer and radioprotector/sensitizer

  2011cites this paper
• MESNA (sodium 2-mercaptoethanesulfonate) for prevention of contrast medium-induced nephrotoxicity - controlled trial.

  2011cites this paper
• Preservation of uroplakins by 2-mercaptoethanesulfonate in cyclophosphamide-induced rat cystitis

  2010cites this paper
• Oxazaphosphorines: new therapeutic strategies for an old class of drugs

  2010influential citation
• Pharmacokinetics and Therapeutic Uses of Mesna

  2010influential citation
• Analysis of BNP7787 thiol-disulfide exchange reactions in phosphate buffer and human plasma using microscale electrochemical high performance liquid chromatography.

  2009cites this paper
• Effect of Glutathione Depletion on Ifosfamide Nephrotoxicity in Rats

  2008cites this paper
• In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro

  2008cites this paper
• Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells

  2008cites this paper
• Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.

  2007cites this paper
• The role of sulfur in platinum anticancer chemotherapy.

  2007cites this paper
• Ifosfamide toxicity in cultured proximal renal tubule cells

  2007cites this paper
• Mesna protects intestinal mucosa from ischemia/reperfusion injury.

  2006influential citation
• Mesna Excretion and Ifosfamide Nephrotoxicity in Children1

  2006cites this paper
• Oxazaphosphorine Cytostatics : Past-Present-Future

  2006cites this paper
• Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule

  2005cites this paper
• The effect of cytoprotective agents in platinum anticancer therapy.

  2004cites this paper
• Mesna ameliorates intestinal mucosa damage after ifosfamide administration in the rabbit at a dose-related manner.

  2004cites this paper
• Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide

  2004cites this paper
• Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.

  2004cites this paper
• Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols

  2004cites this paper
• Antioxidants during anticancer therapy

  2004cites this paper
• Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy

  2004cites this paper
• Oral bioavailability of mesna tablets

  2004cites this paper
• Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin

  2004cites this paper
• Mesna does not reduce cisplatin induced nephrotoxicity in the rat

  2004cites this paper
• High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

  2004cites this paper
• Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats

  2004cites this paper
• False-PositiveResultsfor Ketone with the Drug Mesna and Other Free-Sulfhydry $ Compounds

  2004cites this paper
• Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent

  2004cites this paper
• Quantification of mesna and total mesna in kidney tissue by high-performance liquid chromatography with electrochemical detection.

  2003cites this paper
• Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites

  2003cites this paper
• Pharmacokinetics of BNP7787 and its metabolite mesna in plasma and ascites: a case report

  2003cites this paper
• Simultaneous determination of BNP7787 and its metabolite mesna in plasma and tissue by micro-HPLC with a dual electrochemical detector.

  2003cites this paper
• Inhibitory effects of 2-mercaptoethane sulfonate and 6-phenylhexyl isothiocyanate on urinary bladder tumorigenesis in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.

  2003cites this paper
• Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide.

  2003cites this paper
• The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG

  2003cites this paper
• Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.

  2003cites this paper
• BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.

  2002cites this paper
• MESNA PROTECTS RATS AGAINST NEPHROTOXICITY BUT NOT CARCINOGENICITY INDUCED BY OCHRATOXIN A, IMPLICATING TWO SEPARATE PATHWAYS

  2002cites this paper
• Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.

  2001cites this paper
• Quantification of BNP7787 (dimesna) and its metabolite mesna in human plasma and urine by high-performance liquid chromatography with electrochemical detection.

  2001cites this paper
• Developmental renal tubular toxicity: a hypothetical framework and experimental approaches☆

  2001cites this paper
• Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells

  1999cites this paper
• The effects of cyclophosphamide and its uroprotective agents, mesna and hyperbaric oxygen, on urinary bladder motility in guinea pigs.

  1999cites this paper
• Reduction of dimesna to mesna by the isolated perfused rat liver.

  1998cites this paper
• Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.

  1998cites this paper
• Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.

  1998cites this paper
• Mesna inactivates platinum agents in vitro.

  1998cites this paper
• Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.

  1997cites this paper
• Ifosfamide Metabolite Chloroacetaldehyde Causes Renal Dysfunction in vivo

  1997cites this paper
• Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy

  1997cites this paper
• Effectiveness of cysteamine and mesna in decreasing intracellular cystine content in cystinosis.

  1996cites this paper
• Prevention by 2‐Mercaptoethane Sulfonate and N‐Acetylcysteine of Renal Oxidative Damage in Rats Treated with Ferric Nitrilotriacetate

  1996cites this paper
• Ifosfamide, mesna, and nephrotoxicity in children.

  1993cites this paper
• Intracellular accumulation of cytosine arabinoside in murine normal and neoplastic lymphocytes following their exposure to sodium 2-mercaptoethanesulphonate.

  1993cites this paper
• Depletion of circulating cyst(e)ine by oral and intravenous mesna.

  1993cites this paper
• Oral mesna: a review.

  1992cites this paper
• A Comparative Analysis of the Urinary Excretion Profiles of Mesna and Argimesna Following Oral Administration to Healthy Volunteers

  1992cites this paper
• Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.

  1992cites this paper
• Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.

  1991cites this paper
• Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphate.

  1991cites this paper
• The stability of mesna in beverages and syrup for oral administration

  1991cites this paper
• Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro. Its potential use in the treatment of superficial bladder cancer.

  1991cites this paper
• Inhibition of tumor cell growth in vitro by 2-mercaptoethanesulfonate (mesna) and other thiols.

  1991cites this paper
• [Ifosfamide-induced urinary bladder lesion and its inhibition by mesna].

  1990cites this paper
• Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro.

  1990cites this paper
• Interaction of Mesna (2-mercaptoethane sulfonate) with the mutagenicity of cyclophosphamide in vitro and in vivo.

  1990cites this paper
• Mechanisms of in vitro immunosuppression by hepatocyte-generated cyclophosphamide metabolites and 4-hydroperoxycyclophosphamide.

  1990cites this paper
• Inhibition of estrogen-induced kidney carcinogenesis in Syrian hamsters by modulators of estrogen metabolism.

  1990cites this paper
• [Urinary bioavailability of sodium-2-mercaptoethanesulfonate (Uromitexan) following intravenous, subcutaneous and continuous subcutaneous administration].

  1989cites this paper
• Mesna excretion and ifosfamide nephrotoxicity in children.

  1989cites this paper
• Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture.

  1989cites this paper
• Disposition of 2-mercaptobenzothiazole and 2-mercaptobenzothiazole disulfide in rats dosed intravenously, orally, and topically and in guinea pigs dosed topically.

  1989cites this paper
• In vitro/in vivo effects of Mesna on the genotoxicity and toxicity of cyclophosphamide--a study aimed at clarifying the mechanism of Mesna's anticarcinogenic activity.

  1988cites this paper
• Complexing activity and excretion of 2,3-dimercapto-1-propane sulfonate in rat kidney.

  1988cites this paper
• Basis and new developments in the field of oxazaphosphorines.

  1988cites this paper
• Arginine 2-mercaptoethane sulfonate and sodium 2-mercaptoethane sulfonate: a comparative study of their effects upon tumour cells.

  1988cites this paper
• Interference of Thio-Compounds with Cis-Diamminodichloroplatinum (DDP) on Tumor Cells in Vitro

  1988cites this paper
• In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.

  1988cites this paper
• Studies on Hemotoxicity of Cyclophosphamide, Doxorubicin and Cis-Diamminodichloroplatinum Combined with Sodium-2-Mercaptoethane Sulfonate

  1988cites this paper
• Metabolism of Glutathione in the Kidney

  1987cites this paper
• The role of glutathione in determining the response of normal and tumor cells to anticancer drugs.

  1987cites this paper
• The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.

  1987cites this paper
• Inhibition of rat hepatic microsomal lipid peroxidation by mesna via glutathione.

  1987cites this paper
• Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.

  1987cites this paper
• Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.

  1987cites this paper
• False-positive results for ketone with the drug mesna and other free-sulfhydryl compounds.

  1987cites this paper
• Mesna--a short review.

  1987cites this paper
• Modulation of chemical carcinogenesis in rats by alkyl lysophospholipids

  1987cites this paper
• Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.

  1987cites this paper
• Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results.

  1987cites this paper
• The interactions of mesna and dimesna with the sulfate exchange in human red blood cells.

  1986cites this paper
• Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats.

  1986cites this paper